Showing results (1-10 of 168) with videos related to
Sort By:
Pageof 17
Current Opinion in HIV and AIDS|July 16, 2021
Immunological effector mechanisms in HIV-1 elite controllersCiputra Adijaya Hartana, Xu G YuCell Reports|December 4, 2023
IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllersCiputra Adijaya Hartana, Melanie Lancien, Ce Gao, et al.The Journal of Clinical Investigation|May 3, 2021
Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllersCiputra Adijaya Hartana, Yelizaveta Rassadkina, Ce Gao, et al.British Journal of Cancer|September 7, 2016
Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumoursCiputra Adijaya Hartana, Johan Kinn, Robert Rosenblatt, et al.Expert Opinion on Biological Therapy|April 16, 2019
Facing the future: challenges and opportunities in adoptive T cell therapy in cancerIsabelle Magalhaes, Claudia Carvalho-Queiroz, Ciputra Adijaya Hartana, et al.Nature|January 4, 2023
Phenotypic signatures of immune selection in HIV-1 reservoir cellsWeiwei Sun, Ce Gao, Ciputra Adijaya Hartana, et al.The Journal of Infectious Diseases|May 18, 2023
Immune Modulation of HIV-1 Reservoir Size in Early-Treated NeonatesCiputra Adijaya Hartana, Pilar Garcia Broncano, Kenneth Maswabi, et al.Plos One|July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathwayCiputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.European Urology|July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder CancerDavid Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.Cell|February 17, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2aMarie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, et al.Pageof 17